https://www.selleckchem.com/MEK.html
RESULTS In hypovitaminosis D subjects with ATD, TSH levels significantly decreased after therapy with cholecalciferol 100.000 IU/month [mean ± SD, TSH at T0 2.67 ± 1.21 vs. TSH at T1 2.28 ± 0.86, p = 0.028]. No significant TSH variation was observed in ATD-neg group, irrespective of treatment dose and duration. As expected, 25OHD levels significantly improved with all monthly doses and especially in the group receiving 100.000 IU/month. CONCLUSIONS Cholecalciferol supplementation improved thyroid function in euthyroid ATD-pos subjects affected with
Like
Comment
Share
